Cancer Research UK logo.
SearchDonate
  • Search

A trial looking at cabazitaxel for cancer of the penis that has come back after treatment (JAVA-P)

Overview

Cancer types:

Penile cancer, Secondary cancers

Status:

Results

Phase:

Phase 2

Details

This trial looked at a chemotherapy drug called cabazitaxel to improve treatment for cancer of the penis. Cancer of the penis is also called penile cancer.

It was for men whose cancer had grown into surrounding tissue or had spread elsewhere in the body. This is locally advanced or advanced cancer.

This trial was open for people to join between 2014 and 2017, and the team published the results in 2019.

Recruitment start: 19 December 2014

Recruitment end: 14 February 2017

How to join

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Dr Amit Bahl

Supported by

NIHR Clinical Research Network: Cancer

Sanofi Aventis

University Hospitals Bristol NHS Foundation Trust

Last reviewed: 25 Mar 2021

CRUK internal database number: 12584

The Dangoor Education logo.

Dangoor Education

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education

Patient Information Forum. Trusted Information Creator.
Plain English Campaign award.

Help and support

An icon of a hand shake.

Questions for your doctor

What to ask your doctor about clinical trials.

An icon of two speech bubbles, indicating a conversation.

Cancer chat forum

Meet and chat to other cancer people affected by cancer.

An icon of a landline phone.

Nurse helpline

Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.